Newamsterdam Pharma (NAMS) Trading Summary
Newamsterdam Pharma (NAMS) experienced a decline of 0.05 % in its share price during the 24‑hour period ending at 05:34 AM Central Europe on Friday, 23 October 2026. At the time of reporting, the stock was trading at USD 21.58 on major exchanges.
- Shares outstanding: 119.5 million
- Market capitalization: USD 2.6 billion
- Volume traded in last 24 hours: USD 26.9 million
Since the close of the previous month, NAMS has fallen 7.85 %. The simple moving average for the last 200 days is USD 30.27. Over the past 52 weeks, the stock reached a high of USD 42.20 on 11 May 2026 and a low of USD 19.58 on 14 October 2026.
24‑Hour Performance of Related Stocks
| Ticker | 24‑Hour Change | Current Price | Market Capitalisation | Additional Metrics |
|---|---|---|---|---|
| RDC.DE | +3.16 % | EUR 78.45 | EUR 1.6 billion | – |
| CRBN.AS | –0.33 % | EUR 24.76 | EUR 1.4 billion | P/E = 23.13 |
| OCI.AS | 0 % | EUR 4.10 | EUR 875.5 million | – |
| UQ1.F | –1.01 % | EUR 19.66 | EUR 1.4 billion | – |
| AMG.AS | –1.81 % | EUR 22.86 | EUR 889.6 million | P/E = 167.19 |
Company Overview
Newamsterdam Pharma Co NV is a late‑stage clinical biopharmaceutical company headquartered in Naarden, the Netherlands. The company focuses on the development of oral small‑molecule therapies targeting cardiovascular and metabolic diseases. Its products are intended for patients in the United States and Europe. Further information can be found on the company’s website: www.newamsterdampharma.com . The company’s shares are listed on the Nasdaq stock exchange.
